142 related articles for article (PubMed ID: 7903967)
1. Neuroleptic-induced deficit syndrome (NIDS).
J Clin Psychiatry; 1993 Dec; 54(12):493-500. PubMed ID: 7903967
[No Abstract] [Full Text] [Related]
2. Deficit symptoms in schizophrenia: negative symptoms versus neuroleptic-induced deficits.
Schooler NR
Acta Psychiatr Scand Suppl; 1994; 380():21-6. PubMed ID: 7914043
[TBL] [Abstract][Full Text] [Related]
3. Schizoaffective disorder: a form of schizophrenia or affective disorder?
Evans JD; Heaton RK; Paulsen JS; McAdams LA; Heaton SC; Jeste DV
J Clin Psychiatry; 1999 Dec; 60(12):874-82. PubMed ID: 10665641
[TBL] [Abstract][Full Text] [Related]
4. [Tolerance of neuroleptics, deficit syndrome and cognitive functions].
Kahn JP
Encephale; 1996 Jun; 22 Spec No 2():49-54. PubMed ID: 8767043
[TBL] [Abstract][Full Text] [Related]
5. [Neuroleptic induced deficit syndrome].
Szafrański T
Psychiatr Pol; 1995; 29(3):359-69. PubMed ID: 7652089
[TBL] [Abstract][Full Text] [Related]
6. Food and Drug Administration commentary on methodological issues in negative symptom trials.
Laughren T; Levin R
Schizophr Bull; 2011 Mar; 37(2):255-6. PubMed ID: 21245124
[No Abstract] [Full Text] [Related]
7. [Schizophrenic deficit syndrome and neurologic tolerance].
Verdoux H; Bourgeois M
Encephale; 1996 Jun; 22 Spec No 2():45-7. PubMed ID: 8767042
[TBL] [Abstract][Full Text] [Related]
8. All antipsychotics are equal, but some are more equal than others.
Volavka J; Citrome L
J Clin Psychiatry; 2009 Mar; 70(3):429-30. PubMed ID: 19317959
[No Abstract] [Full Text] [Related]
9. Dyscognitive syndromes in neuroleptic therapy.
Strauss WH; Klieser E; Luethcke H
Pharmacopsychiatry; 1988 Nov; 21(6):298-9. PubMed ID: 2907630
[No Abstract] [Full Text] [Related]
10. [Quality of life of schizophrenic patients and clozapine].
Raoul Y; Manesse P; Delage M
Encephale; 1997 Sep; 23 Spec No 4():12-6. PubMed ID: 9417398
[TBL] [Abstract][Full Text] [Related]
11. Neuroleptic dysphoria: towards a new synthesis.
Voruganti L; Awad AG
Psychopharmacology (Berl); 2004 Jan; 171(2):121-32. PubMed ID: 14647964
[TBL] [Abstract][Full Text] [Related]
12. The effect of risperidone on cognition in patients with schizophrenia.
Stip E; Lussier I
Can J Psychiatry; 1996 Oct; 41(8 Suppl 2):S35-40. PubMed ID: 8899249
[TBL] [Abstract][Full Text] [Related]
13. Neuroleptic drug effects on cognitive function in schizophrenia.
Cleghorn JM; Kaplan RD; Szechtman B; Szechtman H; Brown GM
Schizophr Res; 1990; 3(3):211-9. PubMed ID: 1980613
[TBL] [Abstract][Full Text] [Related]
14. [Deficit schizophrenias].
Puech AJ
Encephale; 1996 Jun; 22 Spec No 2():1. PubMed ID: 8767033
[No Abstract] [Full Text] [Related]
15. [Neuroleptic modification of basic schizophrenic disorders].
Heim M; Morgner J
Psychiatr Neurol Med Psychol (Leipz); 1987 May; 39(5):274-80. PubMed ID: 2888144
[TBL] [Abstract][Full Text] [Related]
16. Involuntary disorders of movement in chronic schizophrenia--the role of the illness and its treatment.
Owens DG
Psychopharmacology Suppl; 1985; 2():79-87. PubMed ID: 2860663
[TBL] [Abstract][Full Text] [Related]
17. Untreated psychosis and long-term outcome in schizophrenia.
Waddington JL; Scully PJ
Schizophr Bull; 1998; 24(1):34-5. PubMed ID: 9502545
[No Abstract] [Full Text] [Related]
18. [Clozapine and treatment of negative symptoms].
Lançon C; Farisse J; Llorca PM
Encephale; 1997 Sep; 23 Spec No 4():7-11. PubMed ID: 9417403
[TBL] [Abstract][Full Text] [Related]
19. [Deficit: the value and difficulty of defining the primary or secondary character of observed symptoms].
Petit M; Langlois S
Encephale; 1996 Jun; 22 Spec No 2():13-8. PubMed ID: 8767036
[TBL] [Abstract][Full Text] [Related]
20. Deficit psychopathology and a paradigm shift in schizophrenia research.
Carpenter WT; Arango C; Buchanan RW; Kirkpatrick B
Biol Psychiatry; 1999 Aug; 46(3):352-60. PubMed ID: 10435200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
